µ½°Ù¶ÈÊ×Ò³
°Ù¶ÈÊ×Ò³
¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃÅ
²¥±¨ÎÄÕÂ

Ç®½­Íí±¨

·¢²¼Ê±¼ä: 2025-05-26 03:35:44±±¾©ÇàÄ걨Éç¹Ù·½Õ˺Å
¹Ø×¢
¡¡¡¡

¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃÅ-¡¾¼ÃÄϸ½Ò»Ò½Ôº¡¿£¬¼ÃÄϸ½Ò»Ò½Ôº,¼ÃÄÏÒõ¾¥¸ù²¿ÓиöСÖ׿é,¼ÃÄÏÒõ¾¥²»²ªÆðÓ²¶È²»¹»,¼ÃÄÏÐÔÉú»î×ÜÊǺܿì,¼ÃÄÏ¿´ÄÐÐÔʲôҽԺ,¼ÃÄϰü¾¥¼¸Ëê×öÊÖÊõºÃ,¼ÃÄÏÎÞ·¨²ªÆðÓ¦¸ÃÔõôµ÷Àí

¡¡¡¡

¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃżÃÄÏÒõÄÒÓÐʱ´ÌÍ´,¼ÃÄÏÒõ¾¥Ãô¸ÐÉñ¾­¹ý¶àÔõô°ì,¼ÃÄÏÄÐÐÔ¸î°üƤÊÖÊõÒ»°ã¶àÉÙÇ®,¼ÃÄÏÄÐ×ÓÑôðôÔçйµÄÖÐÒ©ÖÎÁÆ·½·¨,¼ÃÄÏÔõÑù²ÅÄÜѸËÙ²ªÆð,¼ÃÄÏÄÐÐÔÒ½Ôº±È½ÏºÃ,¼ÃÄÏǰÁÐÏÙÇгýÊõ

¡¡¡¡¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃÅ ¡¡¡¡

The CDC released a report on Friday saying that a rare strain of influenza is particularly severe among children this flu season. According to the CDC, the influenza B virus infection is more common among children and can cause complications, sometimes resulting in deaths. According to CDC figures, 18 deaths among children are attributable to the influenza B strain from September through December. A CDC expert told the Washington Post that despite this year's flu vaccine not being a match with this particular strain of the flu, a vaccine could still be beneficial. ¡°They are close enough so the vaccine offers some protection,¡± Lynnette Brammer told the 672

¡¡¡¡¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃÅ ¡¡¡¡

The Dow fell 460 points Friday as a leading indicator of a US recession and concern about a global slowdown spooked investors.The index shed 1.8%, while the S&P 500 closed down 1.9%. The Nasdaq plunged 2.5%. It was the worst performance for all three major indexes since January 3.The yield on 3-month Treasuries rose above the rate on 10-year Treasuries for the first time since 2007 ¡ª a shift that scared Wall Street. Investors have piled back into stocks after a sell-off in late 2018.The flattening yield curve, or the difference between short- and long-term rates, has worried investors for months. A narrowing spread is typically seen as sign that long-term confidence in the economy is waning, which could signal an eventual economic contraction.Friday's flip added to pressure on the Dow that was building before US markets opened.The index stumbled at the bell on poor manufacturing data from Germany, which also spelled trouble for the country's bond market. The yield on Germany's benchmark 10-year government bond fell below zero for the first time since October 2016.All of that news is fueling Wall Street's ongoing concerns about slowing global growth.White House economic adviser Larry Kudlow told CNBC last year that the spread between 3-month and 10-year Treasury yields was important to watch."It's actually not 10s to 2s; it's 10s to 3-month Treasury bills," Kudlow 1402

¡¡¡¡¼ÃÄÏÔçлµÄµ÷ÀíСÇÏÃÅ ¡¡¡¡

The first participant in a clinical trial for a vaccine to protect against the new coronavirus will receive an experimental dose on Monday, according to a government official.The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle. The official who disclosed plans for the first participant spoke on condition of anonymity because the move has not been publicly announced.Public health officials say it will take a year to 18 months to fully validate any potential vaccine. Testing will begin with 45 young, healthy volunteers with different doses of shots co-developed by NIH and Moderna Inc. There¡¯s no chance participants could get infected from the shots, because they don¡¯t contain the virus itself. The goal is purely to check that the vaccines show no worrisome side effects, setting the stage for larger tests.Dozens of research groups around the world are racing to create a vaccine as COVID-19 cases continue to grow. Importantly, they¡¯re pursuing different types of vaccines ¡ª shots developed from new technologies that not only are faster to produce than traditional inoculations but might prove more potent. Some researchers even aim for temporary vaccines, such as shots that might guard people¡¯s health a month or two at a time while longer-lasting protection is developed.Also in the works: Inovio Pharmaceuticals aims to begin safety tests of its vaccine candidate next month in a few dozen volunteers at the University of Pennsylvania and a testing center in Kansas City, Missouri, followed by a similar study in China and South Korea.Even if initial safety tests go well, ¡°you¡¯re talking about a year to a year and a half¡± before any vaccine could be ready for widespread use, according to Dr. Anthony Fauci, director of NIH¡¯s National Institute of Allergy and Infectious Diseases.That still would be a record-setting pace. But manufacturers know the wait ¡ª required because it takes additional studies of thousands of people to tell if a vaccine truly protects and does no harm ¡ª is hard for a frightened public.President Donald Trump has been pushing for swift action on a vaccine, saying in recent days that the work is ¡°moving along very quickly¡± and he hopes to see a vaccine ¡°relatively soon.¡±Today, there are no proven treatments. In China, scientists have been testing a combination of HIV drugs against the new coronavirus, as well as an experimental drug named remdesivir that was in development to fight Ebola. In the U.S., the University of Nebraska Medical Center also began testing remdesivir in some Americans who were found to have COVID-19 after being evacuated from a cruise ship in Japan.For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially older adults and people with existing health problems, it can cause more severe illness, including pneumonia. The worldwide outbreak has sickened more than 156,000 people and left more than 5,800 dead. The death toll in the United States is more than 50, while infections neared 3,000 across 49 states and the District of Columbia. The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness may take three weeks to six weeks to recover.___The Associated Press receives support for health and science coverage from the Howard Hughes Medical Institute¡¯s Department of Science Education. The AP is solely responsible for all content. 3597

¡¡¡¡

The New York state Supreme Court in Manhattan has disbarred Michael Cohen, President Donald Trump's former personal attorney and fixer, after Cohen pleaded guilty last year to multiple felony charges, according to a decision released Tuesday.A five-judge panel found that Cohen, who began a three-day stretch of congressional testimony on Tuesday, should be disbarred for his federal conviction for having previously made false statements to Congress, the decision said.Though Cohen's disbarment was widely expected in legal circles, for a onetime trusted legal adviser to the President to be stricken from the roll of attorneys in New York state nevertheless constituted another striking step in the escalating consequences of the investigation into Cohen.Cohen, who pleaded guilty in two cases to an array of charges that included campaign-finance violations connected to his work for Trump, is scheduled to report to prison for a three-year sentence beginning on May 6.The decision was posted online early Tuesday evening. It was released two days earlier than initially intended, according to the New York Law Journal. On Tuesday afternoon, paper copies of the decision, containing the same text but dated February 28, were distributed to reporters in the courthouse press room. Court officials declined to confirm that those copies were legitimate and told CNN the decision was not ready to be released, only to then post it online with Tuesday's date.Lanny Davis, an adviser to Cohen, didn't immediately respond to a request for comment on Cohen's disbarment.Though an attorney for Trump, Rudy Giuliani, on several occasions has raised concerns that Cohen could have violated attorney-client privilege, the decision from the court didn't address that subject.In New York, conviction of a federal felony triggers disbarment if the offense would constitute a felony under state law.The court has repeatedly found that a conviction for making false statements to Congress "is analogous to a conviction under the New York felony of offering a false instrument for filing in the first degree and, therefore, automatic disbarment is appropriate herein," the decision said. 2184

¡¡¡¡

The family that owns well-known consumer brands like Krispy Kreme doughnuts, Keurig Dr. Pepper and Panera Bread say their Nazi ancestors used slave labor during World War II.The Reimann family, which owns the controlling stake in JAB Holdings and is reportedly one of the richest families in Germany, will donate €10 million, or million, to a yet-undisclosed charity after a three-year investigation that it commissioned discovered details of their ancestors' behavior.A family spokesperson said Albert Reimann Sr., who died in 1954, and Albert Reimann Jr., who died in 1984, used Russian civilian prisoners and French prisoners of war as forced labor in their factories during the war, and that they were anti-Semites and avowed supporters of Adolf Hitler.The investigation also found that Reimann Sr. donated to Hitler's paramilitary SS force as early as 1931.Investigators also found a letter from Reimann Jr. to a local mayor complaining that the French prisoners of war weren't working hard enough and should be in prison."Reimann Senior and Reimann Junior were guilty. The two businessmen have passed away, but they actually belonged in prison," said Peter Haft, the chairman and one of the managing partners of JAB Holdings, in an interview with German publication Bild. "We were ashamed and white as sheets. There is nothing to gloss over. These crimes are disgusting." A family spokesperson confirmed the quote to CNN Business.The family expects to publish a book next year that will detail the ties.JAB Holdings, which is based in Luxembourg, also owns Peet's Coffee, Pret A Manger, Einstein's Bagels and Coty.The company acquired most of its best-known brands within the last several years. It took a stake in Coty in the early 1990s, and is the beauty company's largest shareholder. 1810

¾Ù±¨/·´À¡

·¢±íÆÀÂÛ

·¢±í